Relevant bibliographies by topics / Locally advanced carcinoma breast

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Locally advanced carcinoma breast'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Locally advanced carcinoma breast.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Locally advanced carcinoma breast"

1

Jain, Sanjay, Guka Priyan K. M., and M. C. Songara. "Clinico-pathological study of locally advanced breast cancer and their hormone receptor analysis." International Surgery Journal 7, no. 9 (2020): 2951. http://dx.doi.org/10.18203/2349-2902.isj20203774.

Full text
Abstract:
Background: Breast carcinoma is one of the most common malignant tumor of women. Determination of estrogen receptors (ER) and progesterone receptors (PR) status, prior to therapeutic intervention has become standard practice. Survival and response to hormone therapy are most favorable among women who are receptor positive. The aim of this study is to assess the hormone receptor status in locally advanced breast carcinomas and correlate this reactivity pattern with tumor stage, clinical stage and lymph node metastasis. Objective of the study was to co-relate the locally advanced breast cancer a
APA, Harvard, Vancouver, ISO, and other styles
2

Lopez, Marvin J., Dorothy P. Andriole, William G. Kraybill, and Ali Khojasteh. "Multimodal therapy in locally advanced breast carcinoma." American Journal of Surgery 160, no. 6 (1990): 669–75. http://dx.doi.org/10.1016/s0002-9610(05)80772-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yarom, I., M. Steiner, R. Borovik, and I. Rabinovich. "Neoadjuvant chemotherapy in locally advanced breast carcinoma." European Journal of Cancer 29 (January 1993): S79. http://dx.doi.org/10.1016/0959-8049(93)91034-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hobar, Paul Creighton. "Multimodality Treatment of Locally Advanced Breast Carcinoma." Archives of Surgery 123, no. 8 (1988): 951. http://dx.doi.org/10.1001/archsurg.1988.01400320037006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Singhal, Juhi, Sandeep Gupta, and Shivam Sharma. "Role of Breast Conservation Surgery in Patients with Locally Advanced Breast Carcinoma after Neoadjuvant Chemoradiotherapy." International Journal of Science and Research (IJSR) 11, no. 9 (2022): 609–11. http://dx.doi.org/10.21275/mr22912220634.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anderson, William F., Kenneth C. Chu, and Shine Chang. "Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?" Journal of Clinical Oncology 21, no. 12 (2003): 2254–59. http://dx.doi.org/10.1200/jco.2003.07.082.

Full text
Abstract:
Purpose: Inflammatory breast carcinoma (IBC) and noninflammatory locally advanced breast carcinoma (LABC) are both associated with poor prognosis; however, whether they are distinct clinicopathologic entities remains controversial. Materials and Methods: To determine whether IBC and LABC were different, we compared tumor characteristics, prognosis, and age-specific incidence rate patterns in the Surveillance, Epidemiology, and End-Results program. An age of 50 years served as a surrogate marker for menopause. Results: Younger age at diagnosis, poorer tumor grade, and negative estrogen receptor
APA, Harvard, Vancouver, ISO, and other styles
7

Girardi, V., G. Carbognin, L. Camera, et al. "Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging." La radiologia medica 116, no. 1 (2010): 71–83. http://dx.doi.org/10.1007/s11547-010-0590-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Muzikravic, Ljubomir, Dragutin Donat, Jasna Pesic, and Jasna Trifunovic. "Maintaining treatment of locally advanced breast cancer." Archive of Oncology 11, no. 3 (2003): 145–47. http://dx.doi.org/10.2298/aoo0303145m.

Full text
Abstract:
Locally advanced breast cancer is a specific clinic entity, comprising various degrees of breast cancer local and regional extension. This term is applied to nonmetastatic large primary tumors (including inflammatory breast carcinoma), with or without extensive regional lymph node involvement, with a rapid or slow evolution, and usually with poor prognosis. This clinical presentation of mammary carcinoma is common in developing countries (30% to 60%), but also with a remarkable incidence in developed countries (10% to 20%). During many decades patients were treated with radical surgery or radi
APA, Harvard, Vancouver, ISO, and other styles
9

Vieira, René Aloisio da Costa, Silvia Maria Prioli de Souza Sabino, Gustavo Zucca Matthes, Anapaula Hidemi Uema Watanabe, and Lucas Faria Abrahao-Machado. "Giant sclerosing papilloma mimicking locally advanced breast carcinoma." Revista da Associação Médica Brasileira 60, no. 6 (2014): 518–19. http://dx.doi.org/10.1590/1806-9282.60.06.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jenna, Prabhakar, and Sushma Jagadev. "A STUDY OF LOCALLY ADVANCED CARCINOMA OF BREAST." Journal of Evidence Based Medicine and Healthcare 4, no. 68 (2017): 4093–96. http://dx.doi.org/10.18410/jebmh/2017/815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Locally advanced carcinoma breast"

1

Gagno, Sara. "Innovative strategies for tailoring therapy in cancer patient: pharmacogenetics and hormone therapy personalization in metastatic or locally advanced breast cancer patients treated with Exemestane." Doctoral thesis, Università degli studi di Padova, 2015. http://hdl.handle.net/11577/3423964.

Full text
Abstract:
Background: Response to chemotherapeutic agents is highly variable among patients both in terms of efficacy and tolerability; consequently personalization of drug therapy is one of the main objective in cancer treatment in order to reduce adverse drug reactions (ADRs), improve efficacy while decreasing the costs of treatments. Many factors account for inter-individual differences. Among them, patient’s genetic background has attracted interest for personalization of drug therapy (Pharmacogenetics). Breast cancer (BC) is the female most frequently diagnosed malignancy and the primary cause of
APA, Harvard, Vancouver, ISO, and other styles
2

Garieri, Alexandre Pavan. "Produção de VEGF e HIF-1? em pacientes com carcinoma de mama localmente avançado submetidas à quimioterapia neoadjuvante." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/17/17145/tde-24042012-144303/.

Full text
Abstract:
Determinar o valor prognóstico e preditivo do VEGF (vascular endothelial growth factor) e do HIF-1? (Hypoxia-inducible factor-1) em relação à sobrevida livre de doença (SLD) e sobrevida global (SG) em pacientes com carcinoma de mama localmente avançado (CMLA) tratadas primariamente pela quimioterapia neoadjuvante. MATERIAIS E METODOS: VEGF e HIF foram quantificados consecutivamente em plasma de 36 pacientes com CMLA pelo método de ELISA (enzyme labeling immunoassay absorbant) para o VEGF165 e o HIF-1?. O tratamento neoadjuvante foi realizado em todas as pacientes com docetaxel e epirrubicina.
APA, Harvard, Vancouver, ISO, and other styles
3

Atalay, Mustafa Can. "Multidrug Resistance In Locally Advanced Breast Cancer." Phd thesis, METU, 2004. http://etd.lib.metu.edu.tr/upload/12604991/index.pdf.

Full text
Abstract:
ABSTRACT MULTIDRUG RESISTANCE IN LOCALLY ADVANCED BREAST CANCER ATALAY, Mustafa Can Ph. D., Department of Biotechnology Supervisor: Prof. Dr. Ufuk G&Uuml<br>ND&Uuml<br>Z June 2004, 70 pages Breast cancer is the most frequently detected cancer among women. Early diagnosis leads to long term survival when the patients are treated with surgery, radiotherapy, chemotherapy, and hormone therapy. Unfortunately, advanced disease could still be encountered in some patients resulting in a poorer prognosis. The primary treatment modality is chemotherapy for this group of patients. Drug resista
APA, Harvard, Vancouver, ISO, and other styles
4

Cao, Maria Dung. "MR metabolic characterization of locally advanced breast cancer : – treatment effects and prognosis." Doctoral thesis, Norges teknisk-naturvitenskapelige universitet, Institutt for sirkulasjon og bildediagnostikk, 2012. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-16250.

Full text
Abstract:
Brystkreft er den hyppigste kreftsykdommen blant kvinner. Lokalavansert brystkreft utgjør omtrent 10% av alle brystkrefttilfeller og omfatter en heterogen pasientgruppe med ulike prognoser. Pasienter med lokalavansert brystkreft får ofte kjemoterapi før kirurgisk fjerning av tumor, såkalt neoadjuvant kjemoterapi, for å redusere størrelsen på tumoren. Det er stor variasjon i behandlingsrespons for denne pasientgruppen, og det er derfor behov for å utvikle målrettet og individualisert behandling, samt metoder for oppfølging av behandlingsrespons. Metabolomics er en systematisk analyse av småmole
APA, Harvard, Vancouver, ISO, and other styles
5

Silveira, Willian Abraham da. "Genetic profile analysis of tumor stem cells in locally advanced breast cancer." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/17/17145/tde-05012016-144854/.

Full text
Abstract:
INTRODUCTION: Breast cancer is the most common cancer in women worldwide and metastatic dissemination is the principal factor related to death by this disease. Breast cancer stem cells (bCSC), defined in this work as the ALDH1high/LIN-/ESA+ population, are thought to be responsible for metastasis and chemoresistance. The objective of this work is to find gene master regulators, in particular transcription factors (TFs), which are controlling the bCSC phenotype. METHODS: We used in this work two groups of datasets with transcriptome data, the discovery dataset group contains one dataset obtaine
APA, Harvard, Vancouver, ISO, and other styles
6

NAGANAWA, SHINJI, MASATAKA SAWAKI, AKIKO NISHIO, SATOKO ISHIGAKI, HIROKO SATAKE, and MARIKO KAWAMURA. "EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI." Nagoya University School of Medicine, 2011. http://hdl.handle.net/2237/15357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Aguiar, Marco AntÃnio Nasser. "Expression of nuclear factor Kappa B (NF-KB) and Interleukin-18 (IL-18) in inflammatory breast cancer and locally advanced breast cancer." Universidade Federal do CearÃ, 2015. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=15328.

Full text
Abstract:
CoordenaÃÃo de AperfeÃoamento de Pessoal de NÃvel Superior<br>Inflammatory Breast Cancer (IBC) is the most aggressive form of locally advanced breast cancer. It is more common in young women and unfavorably, in most of the times, evolves quickly. Presents with typical signs of inflammation such as hyperemia and hyperthermia its pathogenesis and evolution has been associated with possible participation of inflammatory mediators such as cytokines (TNF-&#945; e IL-1&#946;), enzymes (cyclooxygenase-2 [COX-2] and nitric oxide synthase [iNOS]), as well as, transcription factors (Nuclear Factor kappa
APA, Harvard, Vancouver, ISO, and other styles
8

Hristozova, Tsvetana [Verfasser]. "Characterization of circulating tumor cells in locally advanced squamous cell carcinoma of the head and neck / Tsvetana Hristozova." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2012. http://d-nb.info/1030380716/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Van, Niekerk Wayne. "Late radiation proctitis : the incidence and contributing factors in patients with locally advanced cervical carcinoma treated at Pretoria Academic Hospital." Master's thesis, University of Cape Town, 2003. http://hdl.handle.net/11427/11000.

Full text
Abstract:
Includes bibliographical references.<br>The purpose of the thesis is to determine the incidence of late radiation proctitis in patients treated with radical radiotherapy in Pretoria Academic Hospital during a peroid when hypofractionated radiotherapy and external boosts were being utilised for the treatment of advances carcinoma of the cervix. Possible contributing factors were also examined in an attempt to identify areas where possible changes to our treatment policies would ensure effective palliation without severe late radiation proctitis.
APA, Harvard, Vancouver, ISO, and other styles
10

Hamy, Anne-Sophie. "Identification of Factors Predicting Sensitivity or Resistance to Neoadjuvant Chemotherapy in Breast Cancer Neoadjuvant treatment : the future of patients with breast cancer Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an “option” but an ethical obligation Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status BIRC5 (survivin) : a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort The presence of an in situ component on pre-treatment biopsy is not associated with response to neoadjuvant chemotherapy for breast cancer Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer Interaction between molecular subtypes, stromal immune infiltration before and after treatment in breast cancer patients treated with neoadjuvant chemotherapy COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS129.

Full text
Abstract:
La chimiothérapie néoadjuvante (CNA) est utilisée dans les cancers du sein agressifs ou localement avancés (CS). Au delà des bénéfices cliniques, elle représente une opportunité pour monitorer in vivo la sensibilité d’une tumeur à un traitement.A partir de l’analyse de sets de données de patients traités par CNA, nous souhaitons identifier des mécanismes associes à la résistance ou sensibilité au traitement. Dans la première partie, nous avons évalué des paramètres, cliniques, anatomopathologiques et transcriptomiques. Nous avons démontré que des éléments non explorés comme la présence d’embol
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Locally advanced carcinoma breast"

1

Excellence, National Institute for Clinical. Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer. National Institute for Clinical Excellence, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

White, Harvey. A Colour Atlas of Omental Transposition for Advanced Breast Carcinoma. Mosby International, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

White, Harvey M. D. A Colour Atlas of Omental Transposition for Advanced Breast Carcinoma (Single Surgical Procedures, Vol 42). Year Book Medical Pub, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff, and Madhumita Bhattacharyya. Breast cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0014_update_001.

Full text
Abstract:
Thoracic cancer examines the epidemiology, aetiology, and role of screening and prevention in the reduction of deaths from lung cancer, the majority caused by cigarette smoking. The pathology and genetics of lung cancer, with particular note of the driver mutations, are followed by the symptoms and signs of the disease. Appropriate investigations are described to stage the tumour. The optimum treatment for localised non-small cell lung cancer (NSCLC) is surgical resection, followed in some cases by adjuvant chemotherapy. However, most cases present with disease too advanced for surgery, and fo
APA, Harvard, Vancouver, ISO, and other styles
5

Freer, Phoebe E. Skin Lesions. Edited by Christoph I. Lee, Constance D. Lehman, and Lawrence W. Bassett. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190270261.003.0050.

Full text
Abstract:
Skin lesions are commonly seen on breast imaging. Often, a raised skin lesion is encountered incidentally during screening mammography and can be mistaken for a mass within the breast parenchyma. In most cases, lesions confined within the dermis are benign. Occasionally, focal skin involvement may be the presenting sign of a breast cancer that is either locally extensive to the skin or has an inflammatory component. This chapter reviews the key imaging and clinical features of skin lesions that may be encountered either incidentally on breast imaging or on diagnostic imaging as an area of pati
APA, Harvard, Vancouver, ISO, and other styles
6

Hoskin, Peter. Penis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0012.

Full text
Abstract:
Chapter 8d discusses carcinoma of the penis, which is typically a squamous carcinoma arising on the penile shaft or glands in an uncircumcised patient. Management may be by primary surgery, either total amputation or partial amputation with reconstruction, or primary radiotherapy. Primary radiotherapy is indicated for those patients with T1 and T2 tumours &lt;4 cm in diameter, particularly in those unfit for surgery, those with locally advanced disease and fixed inguinal lymph nodes, and for patients in whom surgical treatment may require total amputation and where they choose to have organ pr
APA, Harvard, Vancouver, ISO, and other styles
7

Hoskin, Peter. Vulva and vagina. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0014.

Full text
Abstract:
Chapter 9b discusses carcinoma of the vulva, which is primarily a surgical disease best treated by wide surgical resection, radical vulvectomy, and inguinal lymph node dissection based on presenting stage. Rarely, locally advanced primary disease may be presented for primary radiotherapy treatment. Postoperative radiotherapy is recommended for tumours invading &gt;7 mm in a vertical direction. The first station regional lymph nodes in the inguinal region are best treated by radical surgical dissection, but fixed inoperable lymph nodes may benefit from primary radiotherapy which may be followed
APA, Harvard, Vancouver, ISO, and other styles
8

Thun, Michael J., and Neal D. Freedman. Tobacco. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0011.

Full text
Abstract:
Tobacco is the leading preventable cause of cancer and other non-communicable diseases worldwide. IARC and the U.S. Surgeon General designate over twenty cancer sites or subsites as causally related to active cigarette smoking, including lung, oral cavity, nasal cavity and accessory sinuses, naso- oro- and hypopharynx, larynx, esophagus (squamous cell carcinoma and adenocarcinoma), stomach, pancreas, colorectum, liver, kidney (adeno- and transitional cell carcinoma), ureter, urinary bladder, uterine cervix, ovary (mucinous), and acute myeloid leukemia. Even this list may be incomplete, as it d
APA, Harvard, Vancouver, ISO, and other styles
9

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff, and Amen Sibtain. Colorectal cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0015_update_001.

Full text
Abstract:
Breast cancer reviews the epidemiology and aetiology of this malignancy, with particular attention to the genetics underlying familial breast cancer, its pathology along with its receptors, oestrogen receptor (ER), the growth factor receptor HER2, and epidermal growth factor receptor (EGFR), and the bearing these have on treatment and prognosis. The benefits of breast cancer screening in the population and families at higher risk are discussed. Presenting symptoms and signs are followed by investigation including examination, bilateral mammography, and core biopsy of suspicious lesions. Manage
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Locally advanced carcinoma breast"

1

Coudert, B., P. Gabez, C. Lamaille, C. De Gislain, F. Mayer, and P. Fargeot. "Neo-Adjuvant chemotherapy in 100 patients with locally advanced carcinoma of the breast." In Cancer Treatment An Update. Springer Paris, 1994. http://dx.doi.org/10.1007/978-2-8178-0765-2_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Frasci, Giuseppe, Giuseppe D’Aiuto, Giovanni Iodice, Renato Thomas, Massimiliano D’Aiuto, and Giuseppe Comella. "Estrogen Receptor-Negative and HER-2/neu-Positive Locally Advanced Breast Carcinoma: Therapy with Paclitaxel and Granulocyte-Colony Stimulating Factor." In Methods of Cancer Diagnosis, Therapy and Prognosis. Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-8369-3_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sarkar, Diptendra Kumar. "Locally Advanced Breast Cancer." In Breast Diseases. CRC Press, 2023. http://dx.doi.org/10.1201/9780367821982-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Drago, Stefano P., and Giovanni Battista Grassi. "Locally Advanced Breast Cancer." In Oncologic Breast Surgery. Springer Milan, 2014. http://dx.doi.org/10.1007/978-88-470-5438-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kuciejewska, Aleksandra, and Ian E. Smith. "Locally Advanced Breast Cancer." In Surgery in Breast Cancer and Melanoma. Springer London, 2010. http://dx.doi.org/10.1007/978-1-84996-435-7_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Senkus, Elżbieta, and Aleksandra Łacko. "Locally Advanced Breast Cancer." In Breast Cancer Management for Surgeons. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56673-3_48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ho, Alice, and Simon N. Powell. "Locally Advanced Breast Cancer." In Target Volume Delineation and Field Setup. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28860-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Davila, E., and L. M. Toonkel. "Locally Advanced Breast Cancer." In High-Risk Breast Cancer. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-74728-1_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ho, Alice, Ase Ballangrud, Guang Li, Kate Krause, Chun Siu, and Simon N. Powell. "Locally Advanced Breast Cancer." In Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy. Springer International Publishing, 2014. http://dx.doi.org/10.1007/174_2014_990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kuciejewska, Aleksandra, and Ian E. Smith. "Locally Advanced Breast Cancer." In General Surgery. Springer London, 2009. http://dx.doi.org/10.1007/978-1-84628-833-3_153.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Locally advanced carcinoma breast"

1

Belluco, Rosana Zabulon Feijó, Carolina Gaze Gonçalves Fontenele Gomes, Paulo Eduardo Silva Belluco, et al. "LOCALLY ADVANCED SYNCHRONOUS BILATERAL BREAST CANCER: A RARE CASE REPORT." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2083.

Full text
Abstract:
Introduction: Synchronous bilateral breast cancer (SBBC) consists of the simultaneous presence of two primary tumors at diagnosis. There is no consensus on its origin, and it may be a metastasis of a primary lesion or a second independent tumor. The incidence of SBBC has been reported to be approximately 3%. The prognosis of SBBC was considered to be reserved, which is why bilateral mastectomy is the preferred approach. Case report: A 44-year-old patient with no family record of gynecological neoplasm sought care reporting bilateral breast pain and palpable nodular lesions on the breasts. On e
APA, Harvard, Vancouver, ISO, and other styles
2

Branquinho, Luciano Ipólito, Wesley Justino Magnabosco, Raphael Luiz Haikel, René Aloísio da Costa Vieira, and Idam de Oliveira Junior. "The use of latissimus dorsi myocutaneous flap in locally advanced breast carcinoma." In Brazilian Breast Cancer Symposium 2024. Mastology, 2024. http://dx.doi.org/10.29289/259453942024v34s1058.

Full text
Abstract:
Objective: This study aimed to evaluate the impact of the latissimus dorsi (LD) muscle myocutaneous flap in closing moderate to large chest wall defects in locally advanced breast carcinoma. Methodology: This study was approved by the Ethics Committee under number CAAE: 45093521.3.0000.5437. A retrospective study was performed during 2011– 2019 at a Tertiary Oncology Hospital, in patients submitted to mastectomy, and LD was necessary for chest wall closure. Tumor characteristics, resected area, surgical complications, and recurrence were evaluated. Results: During this period, 22 patients unde
APA, Harvard, Vancouver, ISO, and other styles
3

Oliveira, Persis Araújo, Juliana Campelo Aragão Bitencourt, and Lorena Natali Cardoso Fernandes Caldas. "DIAGNOSTIC CHALLENGE OF A LOCALLY ADVANCED LESION: CASE REPORT OF PRIMARY BREAST ANGIOSARCOMA." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1082.

Full text
Abstract:
Introduction: Primary angiosarcoma of the breast (PAOB) is a class of extremely rare sarcomas, with an incidence rate of 1/2,000 cases of breast cancer worldwide. It is more frequent in 20- and 50-year-old women without history of previous cancer and commonly described in the left breast. Clinical presentation can be the same as usual breast cancer and histology can mimic poorly differentiated ductal carcinoma, which is why immunohistochemistry should be performed. Swelling, a feeling of fullness and exponential growth within the breast are frequent complaints, as noted by Kunkiel et al. in th
APA, Harvard, Vancouver, ISO, and other styles
4

Assunção, Silvaleide Ataides, Vinicius Lemos Nascimento, Bruno Henrique de Aguiar Brito, et al. "NTRK MUTATION IN ADENOID CYSTIC CARCINOMA: A RARE TYPE OF TRIPLE NEGATIVE." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2072.

Full text
Abstract:
Introduction: Breast cancer is one of the neoplasms that most cause death in women. Among these, there are some subtypes of greater biological aggressiveness, such as triple negative and HER overexpressed, which are associated with greater recurrence and mortality. Adenoid cystic carcinoma (ACC), salivary gland type, represents less than 0.1% of primary breast carcinomas and has indolent biological behavior and favorable prognosis compared with nonspecial triplenegative types. Case Report: A 51-year-old woman diagnosed with locally advanced ACC in the right breast, with negative immunohistoche
APA, Harvard, Vancouver, ISO, and other styles
5

El-Helou, Etienne, Catalin-Florin Pop, Ammar Shall, et al. "PRIMARY INVASIVE DUCTAL CARCINOMA OF AXILLARY ACCESSORY BREAST." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2094.

Full text
Abstract:
Primary accessory breast cancer is an extremely rare pathology, representing less than 1% of all breast cancers, and it is found in more than 90% of cases in the axilla. The diagnosis of accessory axillary breast cancer (AABC) is often late and at an advanced stage, with an average delay of 40.5 months. Histological sampling and immunohistochemical results confirm the diagnosis. Most patients are diagnosed with stage II disease or higher, so it is considered to have a poor prognosis. There is no proper management for AABC; it follows the guidelines for orthotopic pectoral breast cancer. We the
APA, Harvard, Vancouver, ISO, and other styles
6

Calabria, André Chaves. "PALPEBRAL METASTASIS 11 YEARS AFTER DIAGNOSIS OF DUCTAL BREAST CARCINOMA." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1040.

Full text
Abstract:
Introduction: We seek to report a rare case of metastasis of infiltrating ductal carcinoma of the breast in the eyelid with a presentation 11 years after diagnosis of the primary tumor. Ocular metastasis needs to be recognized, because although it has limited survival, a timely diagnosis and treatment can significantly improve the quality of life of these patients. Case report: M.S.V., female, 59 years old, presented with locally advanced right breast cancer, clinical stage T3N1M0, with a histopathological diagnosis of infiltrating ductal carcinoma by percutaneous biopsy in 2008. Initially sub
APA, Harvard, Vancouver, ISO, and other styles
7

Zardo, Bianca Ceratti, Alexandre Pedroso de Albuquerque Olmedo, Andrea Barlezze, Alan Azambuja, and Ruben Rodriguez. "Malignant tumor of the peripheral nerve sheath induced after radiotherapy for breast cancer: a case report and therapeutic approach." In XXVI Brazilian Mastology Congress. Mastology, 2024. https://doi.org/10.29289/259453942024v34s2007.

Full text
Abstract:
Introduction: We present the case of patient I.R., a 69-year-old woman, who was diagnosed with invasive ductal carcinoma of the breast in June 2014. She underwent breast-conserving surgery, radiotherapy, and hormone therapy. After nine years, magnetic resonance imaging revealed a mass in the thoracoabdominal region. Subsequent examinations identified a solid nodule in the right breast. A biopsy diagnosed a spindle cell neoplasm. In June 2023, she underwent a right mastectomy with chest wall reconstruction. The pathological examination revealed a malignant tumor of the peripheral nerve sheath i
APA, Harvard, Vancouver, ISO, and other styles
8

Paulinelli, Régis Resende, Luiz Fernando Jubé Ribeiro, Thauana Dias Santos, Elisana Maria Santos Caires, Marilha Gabriella Martins Pontes, and Bruna Morais Faria. "ONCOPLASTIC MAMMAPLASTY WITH DISGUISED GEOMETRIC COMPENSATION." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2020.

Full text
Abstract:
Objective: To evaluate the results and follow-up of retrospective cohort of patients submitted to a new technique of oncoplastic mammaplasty, referred to as disguised geometric compensation mammaplasty (DGCM), which is suitable for tumors involving the glandular tissue in the lateral or medial pillars of the mammaplasty. Materials and Methods: A total of 25 patients with breast tumor involving the pillars of the mammaplasty were included, of whom 20 (80.00%) had invasive ductal carcinoma, 3 (12.00%) had phyllodes tumor, 1 (4.00%) had invasive lobular carcinoma, and 1 (4.00%) had in situ ductal
APA, Harvard, Vancouver, ISO, and other styles
9

Franca, Flávia Cardoso, René Aloisio da Costa Vieira, and Idam de Oliveira-Junior. "Forequarter amputation in patients with breast cancer: a systematic literature review." In Brazilian Breast Cancer Symposium 2024. Mastology, 2024. http://dx.doi.org/10.29289/259453942024v34s1020.

Full text
Abstract:
Objective: The objective of this stusy was to carry out a systematic review of the literature, evaluating the impact of forequarter amputation in locoregional control and survival of patients with breast cancer. Methodology: Based on resolution 466/12, the Research Ethics Committee evaluation was not necessary. Systematic literature review using eight databases. The PICOS and PRISMA methodologies were used. Two evaluators selected the articles, and the data were summarized in a standardized form. Results: Of 1326 articles initially selected on December 31, 2022, 55 articles served as the basis
APA, Harvard, Vancouver, ISO, and other styles
10

Cerda, Rodrigo González, Florencia Belmar, Jaime Letzkus, et al. "Report of a series of cases of breast cancer during pregnancy in a public hospital in Santiago de Chile." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1066.

Full text
Abstract:
Objective: The objective of this study was to report 14 cases of breast cancer during pregnancy and puerperium at the San Borja Arriarán Clinical Hospital in Chile between 2016 and 2022 and analyze the type of treatment, response to treatment, and possible complications of pregnancy associated with chemotherapy. Methodology: This is a retrospective descriptive analysis of a database of breast cancer diagnosed and treated during pregnancy and the puerperium. Prognostic factors, stage, type of treatment, clinical and pathological response, gestational age at delivery, and newborn weight, in addi
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Locally advanced carcinoma breast"

1

Sun, Xueqing, Youqi Zhu, and Yong Xin. Anti-angiogenesis agents plus chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.8.0076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Klifa, Catherine. MRI Study of Uninvolved Breast Tissue for Patients With Locally Advanced Breast Cancer Undergoing Pre-Operative Chemotherapy. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada477348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, Wanfang, Shaojie Li, Wei Ge, Linlin Bu, and Qiuji WU. Additional immunotherapy to standard of care for unresectable locally advanced head and neck squamous cell carcinoma: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.1.0102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gomer, Charles J. Photodynamic Therapy Oxidative Stress as a Molecular Switch Controlling Therapeutic Gene Expression for the Treatment of Locally Recurrent Breast Carcinoma. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada396793.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Viglianti, Benjamin, and Mark W. Dewhirst. Predicted Drug Concentration Distribution Using a Validated Finite Element Model in Locally Advanced Breast Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada427760.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schiff, Peter B. Trial Combining Taxol and Radiation Therapy for Treatment of Locally Advanced Breast Cancer. Phase 1. Defense Technical Information Center, 1996. http://dx.doi.org/10.21236/ada323556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pareel, Vibhay, Shen Zhang, and Aldrich Ong. Stereotactic Radiation therapy in early and locally advanced inoperable renal cell carcinoma: treatment outcomes, patterns of failure and risk factors. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.3.0083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Braun, Rodney D. Use of Mitochondria-Specific Dye MKT-077 as a Radiosensitizer to Preoperatively Treat Locally Advanced Breast Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada484788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Carey, Lisa A. P53 Mutation Analysis to Predict Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada433971.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Carey, Lisa A. P53 Mutation Analysis to Predict Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada420856.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Locally advanced carcinoma breast' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography